Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$1,45,870 Mln
P/E Ratio
18.24
P/B Ratio
1.65
Industry P/E
--
Debt to Equity
--
ROE
0.09 %
ROCE
6.26 %
Div. Yield
6.69 %
Book Value
16.23
EPS
1.41
CFO
$1,77,131.00 Mln
EBITDA
$2,14,159.00 Mln
Net Profit
$1,34,534.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Pfizer (PFE)
| -1.28 | 1.16 | 1.63 | -5.21 | -21.68 | -1.89 | -2.09 |
|
BSE Sensex
| -2.43 | 0.54 | -3.62 | 6.02 | 9.68 | 21.97 | 10.37 |
|
S&P 100
| -5.83 | -8.82 | -5.17 | 11.62 | 10.16 | 19.69 | 11.59 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Pfizer (PFE)
| -7.79 | -43.81 | -13.23 | 60.42 | -0.82 | -10.24 | 20.39 |
|
S&P 100
| 29.04 | 30.83 | -22.12 | 27.55 | 19.30 | 29.47 | -5.82 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 211.96 | 3,77,520.59 | 89.18 | 62.52 | |
| 842.57 | 7,38,753.77 | 70.24 | 84.41 | |
| 163.02 | 3,95,817.88 | 28.32 | 20.06 | |
| 94.73 | 2,39,266.51 | 14.05 | 40.81 |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and... migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Address: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 Read more
Chairman of the Board & CEO
Dr. Albert Bourla D.V.M., Ph.D.
Chief Financial Officer & Executive VP
Mr. David M. Denton
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Pfizer Inc (PFE) stood at -- as on 31-Dec-24
The share price of Pfizer Inc (PFE) is $26.19 (NYSE) as of 20-Mar-2025 16:27 EDT. Pfizer Inc (PFE) has given a return of -21.68% in the last 3 years.
Pfizer Inc (PFE) has a market capitalisation of $ 145,870 Mln as on 17-Mar-2025. As per Value Research classification, it is a Large Cap company.
The P/E ratio of Pfizer Inc (PFE) is 18.24 times as on 17-Mar-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Pfizer Inc (PFE) and enter the required number of quantities and click on buy to purchase the shares of Pfizer Inc (PFE).
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Address: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192
The CEO & director of Dr. Albert Bourla D.V.M., Ph.D.. is Pfizer Inc (PFE), and CFO & Sr. VP is Mr. David M. Denton.
There is no promoter pledging in Pfizer Inc (PFE).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
83,505
|
|
|
39,755
|
|
|
36,677
|
|
|
23,540
|
| Pfizer Inc. (PFE) | Ratios |
|---|---|
|
Return on equity(%)
|
8.85
|
|
Operating margin(%)
|
23.48
|
|
Net Margin(%)
|
12.62
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Pfizer Inc (PFE) was $8,031 Mln.
$-0.02
(
